Sorafenib dose escalation is not uniformly associated with blood pressure elevations in normotensive patients with advanced malignancies.
Clinical Pharmacology And Therapeutics
Karovic, S S; Wen, Y Y; Karrison, T G TG; Bakris, G L GL; Levine, M R MR; House, L K LK; Wu, K K; Thomeas, V V; Rudek, M A MA; Wright, J J JJ; Cohen, E E W EE; Fleming, G F GF; Ratain, M J MJ; Maitland, M L ML